Sample A: Cover Page of Thesis, Project, or Dissertation Proposal
Sample A: Cover Page of Thesis, Project, or Dissertation Proposal
Sample A: Cover Page of Thesis, Project, or Dissertation Proposal
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Figure 4.5: Kaplan-Meyer survival curves f<strong>or</strong> Osteopontin. ProbeSet 34342_s_at (SPP1) survival rates<br />
with respect to stage progression. The significance <strong>of</strong> the osteopontin expression levels is presented in the<br />
sub label along the x-axis: RMA came the closest to a p-value <strong>of</strong> 0.05. The cut<strong>of</strong>fs in the legends represent<br />
the log expression threshold which divides the sub-populations. Note that in the far right graph dCHIP<br />
signal interpretation <strong>of</strong> the data an individual stage I patient has switched patient groups, having an<br />
expression level above the 7.24 cut-<strong>of</strong>f.<br />
After examining the differences in survival statistics and taking into account the relatively<br />
elevated expression level <strong>of</strong> osteopontin in the three previously mentioned n<strong>or</strong>mal samples, we<br />
further divided the data. Supp<strong>or</strong>t f<strong>or</strong> this decision can be found in the maximum tum<strong>or</strong> pathology<br />
as rep<strong>or</strong>ted by Bhattacharjee, et al. in the supplementary data to that article [3]. A mean cut-<strong>of</strong>f<br />
<strong>of</strong> 75% tum<strong>or</strong> pathology was established; the consequent associations between osteopontin<br />
expression level, tum<strong>or</strong> pathology, and stage are presented in Figures 4.6 and 4.7. Figure 4.6 is<br />
the level <strong>of</strong> osteopontin expression compared to patient survival f<strong>or</strong> patients with greater than<br />
103